Mechanism of action of lomefloxacin
- PMID: 2168142
- PMCID: PMC171763
- DOI: 10.1128/AAC.34.6.1088
Mechanism of action of lomefloxacin
Abstract
The inhibition of supercoiling activity of reconstituted Escherichia coli DNA gyrase by lomefloxacin, ciprofloxacin, and norfloxacin was determined. The concentrations of quinolones needed to inhibit DNA synthesis in Escherichia coli, Enterobacter cloacae, Serratia marcescens, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus were also measured. The kinetics of uptake of [14C]lomefloxacin and unlabeled lomefloxacin into whole cells of E. coli KL-16 and S. aureus NCTC 8532 and the induction of RecA in E. coli GC2241 were assayed. All strains had wild-type susceptibilities to quinolones. The concentration of quinolones needed to inhibit DNA synthesis by 50% correlated with the MIC for members of the family Enterobacteriaceae and P. aeruginosa. The concentration of quinolones needed to inhibit DNA synthesis by 50% for late-logarithmic-phase S. aureus also correlated with the MIC, unlike the data from early-logarithmic-phase cultures. E. coli and S. aureus showed a similar pattern of uptake kinetics of [14C]lomefloxacin and unlabeled lomefloxacin, indicating that the difference in the susceptibilities of the two species is probably due to different target site affinities. Essentially, lomefloxacin was less active than ciprofloxacin and ofloxacin and had activity similar to those of norfloxacin and enoxacin.
Similar articles
-
In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones.Antimicrob Agents Chemother. 1988 May;32(5):656-62. doi: 10.1128/AAC.32.5.656. Antimicrob Agents Chemother. 1988. PMID: 3164987 Free PMC article.
-
In vitro activity of lomefloxacin against multiply resistant Pseudomonas aeruginosa, Enterobacter cloacae, and Staphylococcus epidermidis.Diagn Microbiol Infect Dis. 1989 May-Jun;12(3 Suppl):13S-16S. doi: 10.1016/0732-8893(89)90059-x. Diagn Microbiol Infect Dis. 1989. PMID: 2507220
-
Bactericidal activity of lomefloxacin SC 47111 (NY-198) and ciprofloxacin against selected pathogens.Diagn Microbiol Infect Dis. 1989 May-Jun;12(3 Suppl):29S-34S. doi: 10.1016/0732-8893(89)90062-x. Diagn Microbiol Infect Dis. 1989. PMID: 2791495
-
The mode of action of 4-quinolones and possible mechanisms of resistance.J Antimicrob Chemother. 1986 Nov;18 Suppl D:21-9. doi: 10.1093/jac/18.supplement_d.21. J Antimicrob Chemother. 1986. PMID: 3542946 Review.
-
Clinical pharmacokinetics of the newer antibacterial 4-quinolones.Clin Pharmacokinet. 1988 Feb;14(2):96-121. doi: 10.2165/00003088-198814020-00003. Clin Pharmacokinet. 1988. PMID: 3282749 Review.
Cited by
-
Efficacy and safety of lomefloxacin on bacterial extraocular disease in the horse.J Vet Med Sci. 2015 Jul;77(7):829-35. doi: 10.1292/jvms.14-0507. Epub 2015 Mar 15. J Vet Med Sci. 2015. PMID: 25787926 Free PMC article.
-
Mode of action of the new quinolones: new data.Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):223-31. doi: 10.1007/BF01966994. Eur J Clin Microbiol Infect Dis. 1991. PMID: 1650698 Review.
-
Cultivation in Space Flight Produces Minimal Alterations in the Susceptibility of Bacillus subtilis Cells to 72 Different Antibiotics and Growth-Inhibiting Compounds.Appl Environ Microbiol. 2017 Oct 17;83(21):e01584-17. doi: 10.1128/AEM.01584-17. Print 2017 Nov 1. Appl Environ Microbiol. 2017. PMID: 28821547 Free PMC article.
-
New quinolones and gram-positive bacteria.Antimicrob Agents Chemother. 1994 Feb;38(2):163-9. doi: 10.1128/AAC.38.2.163. Antimicrob Agents Chemother. 1994. PMID: 8192436 Free PMC article. Review. No abstract available.
-
Inhibition by quinolones of DNA gyrase from Staphylococcus aureus.Antimicrob Agents Chemother. 1991 Jul;35(7):1489-91. doi: 10.1128/AAC.35.7.1489. Antimicrob Agents Chemother. 1991. PMID: 1656864 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases